The TSQ Fortis Triple Quadrupole Mass Spectrometer from Thermo Fisher Scientific offers fast, robust liquid chromatography-mass spectrometry (LC-MS/MS) analysis for clinical research laboratories.
The Thermo Scientific TSQ Fortis Triple Quadrupole Mass Spectrometer allows clinical research laboratory scientists who face challenges in developing reproducible and reliable methods for the quantitation of analytes in biological matrices to achieve higher productivity while meeting laboratory demands.
The mass spectrometer is suited for applications that demand speed, robustness, and sensitivity for the quantitation of compounds in biological matrices by users with varying levels of expertise.
Features include:
The instrument’s platform is built on a foundation of shared hardware and software components and can be paired with a range of high-performance Thermo Scientific liquid chromatography systems. This pairing capability enables users to go from single-sample-based experiments to validation to routine high-volume screening and quantification, the company reports.
Source: Thermo Fisher Scientific
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Mechanistic Hypothesis of Toxicity: Driving Decision Making in Preclinical Translation
August 5th 2025Mechanistic toxicity hypothesis is essential in guiding decision-making and predicting toxicities during the preclinical stages of drug development. The authors highlight the growing importance of integrating advanced technologies like mass spectrometry imaging into toxicology to enhance preclinical translation, foster innovation in therapeutic development, and ultimately improve drug safety and efficacy.